News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Sorin Group S.p.A. Announces Strong Second Quarter 2009 Results and Increases Full Year Guidance
July 30, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MILAN--(BUSINESS WIRE)--Q2 09 Results highlights: Consolidated revenues at € 181.5 million, up 9.8% (4.9% at constant exchange rates) versus Q2 08;
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Podcast
MAHA Report Emphasizes Vaccines, Safety Vexes Viking’s Obesity Win, Novo Gains Momentum
August 20, 2025
·
2 min read
·
Heather McKenzie
Immuno-oncology
Genentech Walks Away From $2B Partnership With Adaptive Biotechnologies
August 19, 2025
·
1 min read
·
Tristan Manalac
Collaboration
VantAI Links With Halda in Potential $1B+ Proteomics Pact
August 19, 2025
·
2 min read
·
Tristan Manalac
Manufacturing
Oral Wegovy’s Pending Approval Puts Spotlight on Viability of High-Dose Peptides
August 19, 2025
·
5 min read
·
Nick Paul Taylor
